Harvard 3rd Annual Update in Neuro-Oncology 2023

Overview

Harvard 3rd Annual Update in Neuro-Oncology 2023 is a comprehensive three-day digital course providing an in-depth review of the diagnosis and multidisciplinary management of pediatric and adult patients with primary and metastatic central and peripheral nervous system tumors. This course integrates modern molecular neuropathology and neuroradiology concepts essential for accurate tumor classification and patient care.

On-demand neuro-oncology education — accessible anytime, anywhere. All agenda sessions are delivered in Eastern Daylight Time (EDT).

Agenda

This detailed agenda covers key topics over three days, focusing on pediatric neuro-oncology, adult neuro-oncology, and neurological complications of cancer. Sessions include expert presentations and live question and answer segments.

• Welcome: Pediatric Neuro-Oncology Session — Mariella Filbin, MD, PhD
• Keynote: CAR T Cell Therapy for Diffuse Midline Gliomas — Michelle Monje, MD, PhD
• WHO Classification, Pediatric CNS Tumors — Sanda Alexandrescu, MD
• Embryonal Tumors — Scott Pomeroy, MD, PhD
• Break
• Pediatric Low-Grade Gliomas — Susan Chi, MD
• Pediatric High-Grade Gliomas — Mariella Filbin, MD, PhD
• Ependymomas and Glioneuronal Tumors — Pratiti (Mimi) Bandopadhayay, MBBS, PhD
• Live Question & Answer Session — Mariella Filbin, MD, PhD
• Break
• Choroid Plexus Tumors — Viviana Benitez, MD
• Pineal Tumors — Shannon MacDonald, MD
• Germ Cell Tumors — Aaron Yeo, MD
• Neurofibromatosis — Scott Plotkin, MD, PhD
• Von Hippel Lindau — Othon Iliopoulos, MD, PhD
• Live Question & Answer Session — Mariella Filbin, MD, PhD
• Adjourn — Mariella Filbin, MD, PhD
• Welcome: Adult Neuro-Oncology — Tracy Batchelor, MD
• Keynote: Surgical Immunotherapy Clinical Trials for Glioblastoma Multiforme (GBM) — E. Antonio Chiocca, MD, PhD
• Advances in Surgery for Brain Tumors — William Curry, MD
• Advances in Imaging for Brain Tumors — Tina Young Poussaint, MD
• Advances in Radiation for Brain Tumors — Helen Shih, MD
• Live Question and Answer Session — Tracy Batchelor, MD
• Break
• WHO Classification for Adult Gliomas — David Louis, MD
• Gliomas, IDH-Mutant — Nicolas Gonzalez Castro, MD, PhD
• Gliomas, IDH-Wildtype — Isabel Arrillaga, MD, PhD
• Advances in Experimental Therapies for Gliomas — David Reardon, MD
• Break
• Meningioma — Wenya Linda Bi, MD, PhD
• CNS Lymphomas — Lakshmi Nayak, MD
• Pituitary Tumors — Pamela Jones, MD
• Live Question & Answer Session — Tracy Batchelor, MD
• Adjourn
• Welcome: Neurological Complications of Cancer — Patrick Wen, MD
• Keynote: Neural Regulation of Cancer — Humsa Venkatesh, PhD
• Metastases to the Brain — Priscilla Brastianos, MD
• Metastases to the Leptomeninges — Ricky McFaline-Figueroa, MD, PhD
• Metastases to the Epidural Space and Spinal Cord — John Chi, MD, MPH
• Live Question and Answer Session — Patrick Wen, MD
• Break
• Paraneoplastic Neurological Syndromes — Eudocia Lee, MD, MPH
• Common Neurological Complications in Cancer Patients — Ugonma Chukwueke, MD, MPH
• Neurological Complications of Cancer Immunotherapies — Jorg Dietrich, MD, PhD
• Managing Long-Term Survivors of CNS Tumors — Deborah Forst, MD
• Live Question and Answer Session — Patrick Wen, MD
• Closing & Adjourn — Tracy Batchelor, MD, MPH

Learning Objectives

Upon completion of this activity, participants will be able to:

• Identify the role of biomarkers in the diagnosis of pediatric and adult CNS and PNS tumors.
• Identify standard and novel treatment approaches to pediatric and adult CNS and PNS tumors.
• Recognize and address neurological complications associated with new cancer therapies.
• Identify and manage long-term complications of CNS and PNS tumors and their treatment.

Speakers

This course features a multidisciplinary faculty of experts in neuro-oncology, including oncologists, radiation oncologists, neurosurgeons, neurologists, neuroradiologists, and neuropathologists. The faculty also represents specialists involved in neurological complications management and related fields.

Target Audience

• Specialty Physicians involved in neuro-oncology care
• Nurses and Pharmacists supporting neuro-oncology patients
• Physician Assistants participating in clinical care
• Psychologists working with neuro-oncology populations

Why This Topic Matters

Harvard 3rd Annual Update in Neuro-Oncology 2023 covers critical advances in the evolving field of neuro-oncology, encompassing diagnosis, classification, and management of CNS and PNS tumors. For clinicians in neurology, neurosurgery, and oncology, staying current on these topics is essential to strengthen expertise and improve patient care confidence.

MedHub Central provides access to this focused neuro-oncology education, supporting professionals with relevant, practical, and evidence-based content to inform clinical decisions and interdisciplinary collaboration.